Ronald McClurg
Equibles does not estimate personal net worth.
About Ronald McClurg
Earlier roles on record: CFO at NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) until June 30, 2026. NEUROONE MEDICAL TECHNOLOGIES Corp reported in an 8-K filed April 30, 2026 that Ronald McClurg retired as Chief Financial Officer, effective June 30, 2026. Ronald McClurg has spoken on 3 earnings calls across 1 company, most recently for NEUROONE MEDICAL TECHNOLOGIES Corp on February 17, 2026. The companies whose calls Ronald McClurg spoke on are classified in the Healthcare sector.
“On April 24, 2026, Ronald McClurg notified NeuroOne Medical Technologies Corporation (the “Company”) of his intention to retire as the Company’s Chief Financial Officer. The effective date of Mr. McClurg’s retirement as Chief Financial Officer will be June 30, 2026.”
Ronald McClurg on recent calls
“Product revenue was $2,900,000 in 2026, compared to product revenue of $3,300,000 in 2025, which included Zimmer’s initial stocking. On a sequential basis, revenue increased 5.5% from $2,700,000 in 2025.”
“Product revenue increased 907% to $2.7 million in the fourth quarter of fiscal 2025 compared to product revenue of $0.3 million in the fourth quarter of fiscal 2024.”
“Product revenue increased 105% to $1.7 million in the third quarter of fiscal 2025 compared to product revenue of $0.8 million in the third quarter of fiscal '24.”
Affiliation history
-
Start not stated–2026-06-30